A citation-based method for searching scientific literature

A E Deconinck, J A Rafael, J A Skinner, S C Brown, A C Potter, L Metzinger, D J Watt, J G Dickson, J M Tinsley, K E Davies. Cell 1997
Times Cited: 556







List of co-cited articles
1460 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.
R M Grady, H Teng, M C Nichol, J C Cunningham, R S Wilkinson, J R Sanes. Cell 1997
499
44


X chromosome-linked muscular dystrophy (mdx) in the mouse.
G Bulfield, W G Siller, P A Wight, K J Moore. Proc Natl Acad Sci U S A 1984
30

The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.
P Sicinski, Y Geng, A S Ryder-Cook, E A Barnard, M G Darlison, P J Barnard. Science 1989
985
25

Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
J Tinsley, N Deconinck, R Fisher, D Kahn, S Phelps, J M Gillis, K Davies. Nat Med 1998
438
24

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.
Joe W McGreevy, Chady H Hakim, Mark A McIntosh, Dongsheng Duan. Dis Model Mech 2015
232
23

Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice.
Alessandra Sacco, Foteini Mourkioti, Rose Tran, Jinkuk Choi, Michael Llewellyn, Peggy Kraft, Marina Shkreli, Scott Delp, Jason H Pomerantz, Steven E Artandi,[...]. Cell 2010
301
18

Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
J M Tinsley, A C Potter, S R Phelps, R Fisher, J I Trickett, K E Davies. Nature 1996
379
16

In vivo gene editing in dystrophic mouse muscle and muscle stem cells.
Mohammadsharif Tabebordbar, Kexian Zhu, Jason K W Cheng, Wei Leong Chew, Jeffrey J Widrick, Winston X Yan, Claire Maesner, Elizabeth Y Wu, Ru Xiao, F Ann Ran,[...]. Science 2016
604
15

Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.
Jeffrey S Chamberlain, Joseph Metzger, Morayma Reyes, DeWayne Townsend, John A Faulkner. FASEB J 2007
226
15

Function and genetics of dystrophin and dystrophin-related proteins in muscle.
Derek J Blake, Andrew Weir, Sarah E Newey, Kay E Davies. Physiol Rev 2002
785
14

Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.
Chengzu Long, Leonela Amoasii, Alex A Mireault, John R McAnally, Hui Li, Efrain Sanchez-Ortiz, Samadrita Bhattacharyya, John M Shelton, Rhonda Bassel-Duby, Eric N Olson. Science 2016
557
14

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
Catherine L Bladen, David Salgado, Soledad Monges, Maria E Foncuberta, Kyriaki Kekou, Konstantina Kosma, Hugh Dawkins, Leanne Lamont, Anna J Roy, Teodora Chamova,[...]. Hum Mutat 2015
293
14

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E Nelson, Chady H Hakim, David G Ousterout, Pratiksha I Thakore, Eirik A Moreb, Ruth M Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F Ann Ran, Winston X Yan,[...]. Science 2016
648
13

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.
H H Stedman, H L Sweeney, J B Shrager, H C Maguire, R A Panettieri, B Petrof, M Narusawa, J M Leferovich, J T Sladky, A M Kelly. Nature 1991
726
13

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Katharine Bushby, Richard Finkel, David J Birnkrant, Laura E Case, Paula R Clemens, Linda Cripe, Ajay Kaul, Kathi Kinnett, Craig McDonald, Shree Pandya,[...]. Lancet Neurol 2010
13

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.
A P Monaco, C J Bertelson, S Liechti-Gallati, H Moser, L M Kunkel. Genomics 1988
906
12

Evidence-based path to newborn screening for Duchenne muscular dystrophy.
Jerry R Mendell, Chris Shilling, Nancy D Leslie, Kevin M Flanigan, Roula al-Dahhak, Julie Gastier-Foster, Kelley Kneile, Diane M Dunn, Brett Duval, Alexander Aoyagi,[...]. Ann Neurol 2012
444
12


Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy.
Foteini Mourkioti, Jackie Kustan, Peggy Kraft, John W Day, Ming-Ming Zhao, Maria Kost-Alimova, Alexei Protopopov, Ronald A DePinho, Daniel Bernstein, Alan K Meeker,[...]. Nat Cell Biol 2013
89
12

Effect of genetic background on the dystrophic phenotype in mdx mice.
William D Coley, Laurent Bogdanik, Maria Candida Vila, Qing Yu, Jack H Van Der Meulen, Sree Rayavarapu, James S Novak, Marie Nearing, James L Quinn, Allison Saunders,[...]. Hum Mol Genet 2016
96
11

Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy.
Thibaut Larcher, Aude Lafoux, Laurent Tesson, Séverine Remy, Virginie Thepenier, Virginie François, Caroline Le Guiner, Helicia Goubin, Maéva Dutilleul, Lydie Guigand,[...]. PLoS One 2014
93
11

Generation of muscular dystrophy model rats with a CRISPR/Cas system.
Katsuyuki Nakamura, Wataru Fujii, Masaya Tsuboi, Jun Tanihata, Naomi Teramoto, Shiho Takeuchi, Kunihiko Naito, Keitaro Yamanouchi, Masugi Nishihara. Sci Rep 2014
85
12

Multiplex genome engineering using CRISPR/Cas systems.
Le Cong, F Ann Ran, David Cox, Shuailiang Lin, Robert Barretto, Naomi Habib, Patrick D Hsu, Xuebing Wu, Wenyan Jiang, Luciano A Marraffini,[...]. Science 2013
11

The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.
G Nigro, L I Comi, L Politano, R J Bain. Int J Cardiol 1990
398
11

Humanizing the mdx mouse model of DMD: the long and the short of it.
Nora Yucel, Alex C Chang, John W Day, Nadia Rosenthal, Helen M Blau. NPJ Regen Med 2018
44
25

Dystrophin protects the sarcolemma from stresses developed during muscle contraction.
B J Petrof, J B Shrager, H H Stedman, A M Kelly, H L Sweeney. Proc Natl Acad Sci U S A 1993
10

Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings.
John G Quinlan, Harvey S Hahn, Brenda L Wong, John N Lorenz, Alexandra S Wenisch, Linda S Levin. Neuromuscul Disord 2004
206
10

Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.
Leonela Amoasii, Chengzu Long, Hui Li, Alex A Mireault, John M Shelton, Efrain Sanchez-Ortiz, John R McAnally, Samadrita Bhattacharyya, Florian Schmidt, Dirk Grimm,[...]. Sci Transl Med 2017
108
10

Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.
Hongmei Lisa Li, Naoko Fujimoto, Noriko Sasakawa, Saya Shirai, Tokiko Ohkame, Tetsushi Sakuma, Michihiro Tanaka, Naoki Amano, Akira Watanabe, Hidetoshi Sakurai,[...]. Stem Cell Reports 2015
321
10

Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
David G Ousterout, Ami M Kabadi, Pratiksha I Thakore, William H Majoros, Timothy E Reddy, Charles A Gersbach. Nat Commun 2015
256
10

Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
Courtney S Young, Ekaterina Mokhonova, Marbella Quinonez, April D Pyle, Melissa J Spencer. J Neuromuscul Dis 2017
42
23

Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.
Jerry R Mendell, Nathalie Goemans, Linda P Lowes, Lindsay N Alfano, Katherine Berry, James Shao, Edward M Kaye, Eugenio Mercuri. Ann Neurol 2016
282
10

Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division.
Nicolas A Dumont, Yu Xin Wang, Julia von Maltzahn, Alessandra Pasut, C Florian Bentzinger, Caroline E Brun, Michael A Rudnicki. Nat Med 2015
253
10

Dystrophin-Deficient Cardiomyopathy.
Forum Kamdar, Daniel J Garry. J Am Coll Cardiol 2016
133
10

CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells.
Yi-Li Min, Hui Li, Cristina Rodriguez-Caycedo, Alex A Mireault, Jian Huang, John M Shelton, John R McAnally, Leonela Amoasii, Pradeep P A Mammen, Rhonda Bassel-Duby,[...]. Sci Adv 2019
93
10

Primary structure of dystrophin-related protein.
J M Tinsley, D J Blake, A Roche, U Fairbrother, J Riss, B C Byth, A E Knight, J Kendrick-Jones, G K Suthers, D R Love. Nature 1992
360
9

The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.
Karen A Lapidos, Rahul Kakkar, Elizabeth M McNally. Circ Res 2004
332
9

Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice.
V M Chapman, D R Miller, D Armstrong, C T Caskey. Proc Natl Acad Sci U S A 1989
175
9

Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
E Araki, K Nakamura, K Nakao, S Kameya, O Kobayashi, I Nonaka, T Kobayashi, M Katsuki. Biochem Biophys Res Commun 1997
81
11


Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.
Chengzu Long, John R McAnally, John M Shelton, Alex A Mireault, Rhonda Bassel-Duby, Eric N Olson. Science 2014
395
9

Muscle development in mdx mutant mice.
J Dangain, G Vrbova. Muscle Nerve 1984
284
9

Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice.
N Deconinck, J Tinsley, F De Backer, R Fisher, D Kahn, S Phelps, K Davies, J M Gillis. Nat Med 1997
191
9

The Pathogenesis and Therapy of Muscular Dystrophies.
Simon Guiraud, Annemieke Aartsma-Rus, Natassia M Vieira, Kay E Davies, Gert-Jan B van Ommen, Louis M Kunkel. Annu Rev Genomics Hum Genet 2015
170
9

Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
Niclas E Bengtsson, John K Hall, Guy L Odom, Michael P Phelps, Colin R Andrus, R David Hawkins, Stephen D Hauschka, Joel R Chamberlain, Jeffrey S Chamberlain. Nat Commun 2017
195
9

A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
Courtney S Young, Michael R Hicks, Natalia V Ermolova, Haruko Nakano, Majib Jan, Shahab Younesi, Saravanan Karumbayaram, Chino Kumagai-Cresse, Derek Wang, Jerome A Zack,[...]. Cell Stem Cell 2016
202
9

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Craig M McDonald, Craig Campbell, Ricardo Erazo Torricelli, Richard S Finkel, Kevin M Flanigan, Nathalie Goemans, Peter Heydemann, Anna Kaminska, Janbernd Kirschner, Francesco Muntoni,[...]. Lancet 2017
190
9

Progress toward Gene Therapy for Duchenne Muscular Dystrophy.
Joel R Chamberlain, Jeffrey S Chamberlain. Mol Ther 2017
100
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.